Hostname: page-component-788cddb947-tr9hg Total loading time: 0 Render date: 2024-10-14T18:04:21.658Z Has data issue: false hasContentIssue false

Lung Cancer Survival Gains: Contributions of Academia and Industry

Published online by Cambridge University Press:  01 January 2021

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns: Health Policy Portal
Copyright
Copyright © American Society of Law, Medicine and Ethics 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bray, F., Ferlay, J., Soerjomataram, I., et al., “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 68, no. 6 (2018): 394-424.Google Scholar
Siegel, R. L., Miller, K. D., and Jemal, A., “Cancer statistics, 2018,” CA: A Cancer Journal for Clinicians 68, no. 1 (2018): 7-30.Google Scholar
Xia, W., Yu, X., Mao, Q., et al., “Improvement of Survival for Non-Small Cell Lung Cancer Over Time,” Onco Targets and Therapy 10 (2017): 4295-4303; Akhtar-Danesh, N. and Finley, C., “Temporal Trends in the Incidence and Relative Survival of Non-Small Cell Lung Cancer in Canada: A Population-Based Study,” Lung Cancer 90 (2015): 8-14; M.C.S. Wong, S.Q. Lao, K.F. Ho, et al., “Incidence and Mortality of Lung Cancer: Global Trends and Association with Socioeconomic Status,” Scientific Reports 7 (2017): 14300.CrossRefGoogle Scholar